Bayesian Capital Management, LP Charles River Laboratories International, Inc. Transaction History
Bayesian Capital Management, LP
- $788 Million
- Q4 2024
A detailed history of Bayesian Capital Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 17,965 shares of CRL stock, worth $2.73 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
17,965Holding current value
$2.73 Million% of portfolio
0.42%Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
705Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$936 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$773 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$620 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$332 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$275 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.73B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...